Suchergebnisse - "Ju, Linling"

PubPharm (27)

1

CircGPC3 promotes hepatocellular carcinoma progression and metastasis by sponging miR-578 and regulating RAB7A/PSME3 expression

enthalten in: Scientific reports | 2024

von Ju, L. | Luo, Y. | Cui, X. | +3

2

Protective autophagy enhances antistress ability through AMPK/ULK1 signaling pathway in human immortalized keratinocytes

enthalten in: Cell biology international | 2024

von Shi, Z. | Wang, J. | Li, M. | +10

3

Prenatal diesel exhaust exposure alters hippocampal synaptic plasticity in offspring

enthalten in: Aging | 2024

von Yu, S. | Zhang, Z. | Qin, Z. | +9

4

Construction of a ceRNA regulatory network to explore potential pathogenesis mechanisms involved in human hepatocellular carcinoma

enthalten in: Scientific reports | 2023

von Liu, Y. | Dong, Z. | Chen, W. | +5

5

circSLCO1B7 suppresses the malignant progression of hepatocellular carcinoma via the miR-556-3p/DAB2IP axis

enthalten in: Aging | 2023

von Ju, L. | Zhou, Q. | Qi, Q. | +6

6

HLA-DR+ mucosal-associated invariant T cells predict poor prognosis in patients with sepsis : A prospective observational study

enthalten in: Scandinavian journal of immunology | 2023

von Tian, L. | Xu, J. | Chen, C. | +6

7

Semaphorin4F is a potential biomarker for clinical progression and prognosis in gastric cancer

enthalten in: International journal of clinical and experimental pathology | 2023

von Wang, H. | Ji, X. | Chen, L. | +4

8

Clinical and Experimental Study of High Mobility Group Box-2 and Valvular Calcification in Elderly Patients with Degenerative Heart Valve Disease

enthalten in: Cardiology | 2023

von Huang, H. | Sun, Q. | Huang, Y. | +6

9

Circular RNA hsa_circ_0051040 Promotes Hepatocellular Carcinoma Progression by Sponging miR-569 and Regulating ITGAV Expression

enthalten in: Cells | 2022

von Ju, L. | Yao, M. | Lu, R. | +8

10

Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway

enthalten in: Oncology reports | 2021

von Lu, R. | Zhou, Q. | Ju, L. | +3